NEW YORK, NY--(Marketwired - February 19, 2014) - Kadmon Corporation, LLC, today announced that Samuel D. Waksal, Ph.D., Chairman and Chief Executive Officer, will present at the RBC Capital Markets 2014 Global Healthcare Conference on Wednesday, February 26th at 9:30 a.m. EST at The Palace Hotel in New York City. Dr. Waksal will provide an overview of Kadmon and its commercial and clinical programs.
A live audio webcast of the presentation will be accessible through Kadmon's website at www.kadmon.com. The webcast will be archived for 90 days.
About Kadmon Corporation
Kadmon Corporation, LLC, is a fully integrated biopharmaceutical company, focused on the development of drugs that target unmet medical needs in areas of serious disease, including oncology, infectious diseases, immunology and neurodegenerative diseases. Kadmon is developing a portfolio of drugs in mid-stage clinical development and a number of monoclonal antibodies undergoing preclinical testing emphasizing emerging concepts in molecular biology and genomics. Kadmon distributes and markets a portfolio of branded and generic drugs for hepatitis C including proprietary high dose ribavirin formulations which are supported by a specialty US sales force with well-established prescriber relationships and unparalleled access to specialty pharmacies. Kadmon is based in New York, New York, with operations in Warrendale, Pennsylvania and Boston, Massachusetts. For more information, visit www.kadmon.com.